ProKidney Corp.
ProKidney Corp., a clinical-stage biotechnology, engages in developing cellular therapy candidates. It is developing Renal Autologous Cell Therapy, an autologous homologous cell admixture that is in a Phase III development program, as well as Phase II cl…
Biotechnology
US, Winston-Salem [HQ]
Cash Flow Statements
5 Records · Starting from 2019In Million USD. Margins, Growth Rates In %
| Metric | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|
| Operating Activities | ||||||
| Operating Cash Flow (OCF) | - - | -25.00 | -50.00 | -77.00 | -90.00 | |
| Operating Cash (Net) | - - | -25.00 | -50.00 | -77.00 | -90.00 | |
| Accounts Receivable | - - | - - | - - | - - | -1.00 | |
| Accounts Payable | - - | - - | - - | - - | 11.00 | |
|
Working Capital
|
- - | - - | - - | - - | - - | |
| Change | - - | - - | 2.00 | -6.00 | 16.00 | |
| Other WC | - - | - - | 2.00 | -6.00 | 18.00 | |
| Investing Activities | ||||||
| Used Cash (Net) | - - | -5.00 | -5.00 | -1.00 | -329.00 | |
| Capital Expenditure | - - | -5.00 | -5.00 | -1.00 | -34.00 | |
| Purchases of Investments | - - | - - | - - | - - | -471.00 | |
| Sale/Maturity of Investment | - - | - - | - - | - - | 175.00 | |
| Property, Plant, Equipment (P&PE) | - - | -5.00 | -5.00 | -1.00 | -34.00 | |
| Acquisitions (Net) | - - | - - | - - | - - | 34.00 | |
| Other Investing Activities | - - | - - | - - | - - | -34.00 | |
| Financing Activities | ||||||
| Used Cash (Net) | - - | -19.00 | -71.00 | -548.00 | -9.00 | |
| Debt Repayment | - - | - - | - - | -35.00 | - - | |
| Dividends Paid | - - | - - | - - | - - | - - | |
|
Common Stock
|
- - | - - | - - | - - | 9 | |
| Issued | - - | - - | 71.00 | 6.00 | - - | |
| Repurchased | - - | - - | - - | - - | -9.00 | |
| Other Financing Activities | - - | 20.00 | 71.00 | 577.00 | -9.00 | |
| Cash Balances | ||||||
| Begin of Period | - - | 15.00 | 4.00 | 20.00 | 490.00 | |
| End of Period | - - | 4.00 | 20.00 | 490.00 | 60.00 | |
| Change | - - | -10.00 | 15.00 | 469.00 | -429.00 | |
| Non-Cash Balances | ||||||
| Depreciation and Amortization | - - | - - | 1.00 | 3.00 | 3.00 | |
| Stock Based Compensation | - - | - - | - - | 74.00 | 30.00 | |
| Other | - - | - - | 4.00 | 40.00 | -93.00 | |
| Highlighted metrics | ||||||
| Free Cash Flow (FCF) | - - | -30.00 | -55.00 | -78.00 | -124.00 | |
| Cash Conversion Cycle (CCC) | - - | - - | - - | - - | - - | |
| Invested Capital | - - | - - | - - | - - | - - | |
|
Other Operating Inflows/Outflows
|
||||||
| Forex Effect on Cash | - - | - - | - - | - - | - - |